In summary, we found dysregulated circulating Tfh and Tfr, as well as an altered Tfh/Tfr ratio, in SLE and IRF5 homozygous risk carriers along with elevated IRF5 expression within the T cell compartment. Here, IRF5 is linked to systemic lupus erythematosus.